The Centers for Disease Control and Prevention (CDC) Director Dr. Robert Redfield has approved a COVID-19 vaccine distribution plan. The approved interim recommendation first offers vaccine distribution to health care workers and residents of long-term care facilities in the initial phase of the vaccination program before offering the vaccine to the general public.
This recommendation comes from an independent panel
of scientific advisors of the Advisory Committee on Immunization Practices (ACIP). Redfield approved their
recommendation after the panel’s 13-1 vote in favor of the distribution plan.
The ACIP stated that this interim recommendation could be updated over the
coming weeks based on additional safety and efficacy data.
COVID-19
Vaccine Timeline
Drugmaker Pfizer Inc., in partnership with German drugmaker
BioNTech, continue to submit data to the U.S. Food and Drug Administration (FDA)
for Emergency Use Authorization (EAU) for their COVID-19 vaccine candidate. As
Pfizer and BioNTech continue to submit data, the FDA has not yet approved a
vaccine for use in the United States. However, according to the FDA, federal
advisory groups will discuss authorization for the Pfizer-BioNTech COVID-19 vaccine
on Dec. 10, 2020. Additionally, drugmaker Moderna Inc. has also applied for EUA
for its COVID-19 vaccine and continues through the approval process.
Pending approval from the FDA, federal officials are prepared
to send 6.4 million doses within 24 hours of the authorization, meaning that the
COVID-19 vaccine could potentially be available to the outlined groups before
the end of 2020. Drugmakers Pfizer Inc. and Moderna Inc. are prepared to
distribute up to 22.5 million vaccine treatments before the end of the year.
What This Means
No comments:
Post a Comment